Pharmaron Beijing Co., Ltd. (SHE:300759)
China
· Delayed Price · Currency is CNY 29.75
-1.17 (-3.78%)
Apr 29, 2026, 3:04 PM CST
Pharmaron Beijing Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1,694 | 1,664 | 1,793 | 1,601 | 1,375 | 1,661 | Upgrade
|
| Depreciation & Amortization | 1,163 | 1,163 | 1,049 | 927.17 | 696.18 | 497.92 | Upgrade
|
| Other Amortization | 106.36 | 106.36 | 96.75 | 81.42 | 69.88 | 79.76 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4.69 | 4.69 | 25.38 | -0.06 | 1.21 | 1.37 | Upgrade
|
| Asset Writedown & Restructuring Costs | -12.79 | -12.79 | 76.56 | -48.03 | -220.52 | -55.91 | Upgrade
|
| Loss (Gain) From Sale of Investments | 50.35 | 50.35 | -544.76 | -21.01 | 71.84 | -285.29 | Upgrade
|
| Provision & Write-off of Bad Debts | 80.28 | 80.28 | 42.95 | 35.83 | - | - | Upgrade
|
| Other Operating Activities | -162.04 | 116.13 | 97.19 | -25.12 | 318.9 | -38.39 | Upgrade
|
| Change in Accounts Receivable | -280.97 | -280.97 | -296.78 | -480.1 | -830.63 | -295.65 | Upgrade
|
| Change in Inventory | -344.96 | -344.96 | -148.07 | 82.43 | -120.89 | -224.88 | Upgrade
|
| Change in Accounts Payable | 616.18 | 616.18 | 327.67 | 461.34 | 584.09 | 641.74 | Upgrade
|
| Change in Other Net Operating Assets | 81.59 | 81.59 | 91.11 | 202.22 | 177.17 | 67.53 | Upgrade
|
| Operating Cash Flow | 2,973 | 3,221 | 2,577 | 2,754 | 2,143 | 2,058 | Upgrade
|
| Operating Cash Flow Growth | 10.76% | 25.01% | -6.42% | 28.50% | 4.12% | 24.83% | Upgrade
|
| Capital Expenditures | -2,692 | -2,669 | -2,041 | -2,865 | -2,950 | -2,093 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.24 | 1.85 | 3.32 | 8.11 | 3.15 | 1.61 | Upgrade
|
| Cash Acquisitions | -992.8 | -1,124 | -22.63 | - | -1,022 | -1,226 | Upgrade
|
| Investment in Securities | 196.83 | -655.77 | -675.58 | 557.56 | 1,699 | -2,020 | Upgrade
|
| Other Investing Activities | 81.26 | 72.99 | 711.25 | 48.81 | 61.13 | 78.79 | Upgrade
|
| Investing Cash Flow | -3,405 | -4,374 | -2,024 | -2,251 | -2,209 | -5,258 | Upgrade
|
| Long-Term Debt Issued | - | 2,866 | 1,322 | 4,171 | 589.81 | 4,621 | Upgrade
|
| Long-Term Debt Repaid | - | -1,947 | -5,295 | -767.08 | -838.53 | -300 | Upgrade
|
| Net Debt Issued (Repaid) | 926.79 | 919.44 | -3,973 | 3,404 | -248.72 | 4,321 | Upgrade
|
| Issuance of Common Stock | 1,203 | 16.71 | 10.51 | 17.33 | - | - | Upgrade
|
| Repurchase of Common Stock | -6.71 | -6.71 | -285.91 | -0.83 | -393.38 | -284.06 | Upgrade
|
| Common Dividends Paid | -537.38 | -531.05 | -542.23 | -444.79 | -404.76 | -284.72 | Upgrade
|
| Other Financing Activities | -3.62 | -21.38 | -5.8 | 939.76 | -370.4 | -91.26 | Upgrade
|
| Financing Cash Flow | 1,582 | 377 | -4,797 | 3,915 | -1,417 | 3,661 | Upgrade
|
| Foreign Exchange Rate Adjustments | -35.73 | -3.93 | 78.14 | 11.43 | 72.99 | -45.52 | Upgrade
|
| Net Cash Flow | 1,114 | -780.27 | -4,166 | 4,429 | -1,410 | 415.78 | Upgrade
|
| Free Cash Flow | 280.16 | 551.97 | 536.02 | -111.78 | -807.04 | -34.78 | Upgrade
|
| Free Cash Flow Growth | -52.20% | 2.98% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1.92% | 3.92% | 4.37% | -0.97% | -7.86% | -0.47% | Upgrade
|
| Free Cash Flow Per Share | 0.16 | 0.31 | 0.30 | -0.06 | -0.45 | -0.02 | Upgrade
|
| Cash Income Tax Paid | - | -101.43 | 110.92 | -54.99 | -235.22 | -22 | Upgrade
|
| Levered Free Cash Flow | -1,018 | -310.13 | 17.01 | -1,456 | -1,678 | -479.46 | Upgrade
|
| Unlevered Free Cash Flow | -897.95 | -189.63 | 169.34 | -1,342 | -1,573 | -427.54 | Upgrade
|
| Change in Working Capital | 48.87 | 48.87 | -59.42 | 202.26 | -169.29 | 197.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.